Clinical trials
Phase 2 Acquired Immunodeficiency Syndrome trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 6 |
| Canadian Immunodeficiency Research Collaborative | 3 |
| GlaxoSmithKline | 2 |
| Hoffmann-La Roche | 2 |
| Amgen | 1 |
| Argos Therapeutics | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Myrexis Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 22 |
| HIV Infections | 14 |
| Infections | 7 |
| AIDS-Related Complex | 2 |
| Virus Diseases | 2 |
| AIDS-Related Opportunistic Infections | 1 |
| Anus Neoplasms | 1 |
| Cytopenia | 1 |
| Hepatitis B | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.